Related Experiment Videos
Oxidative stress and cardiovascular disease
1Department of Medicine, St Boniface General Hospital, Winnipeg, Manitoba.
Insights
Oxidative stress significantly contributes to cardiovascular diseases like atherosclerosis and heart failure. However, current evidence does not support using antioxidant therapy for preventing cardiovascular disease.
Area of Science:
- Cardiovascular Research
- Oxidative Stress Biology
Background:
- Oxidative stress is implicated in the development of atherosclerosis, endothelial dysfunction, platelet aggregation, and heart failure.
- Understanding the role of oxidative stress is crucial for cardiovascular disease management.
Purpose of the Study:
- To evaluate the evidence linking oxidative stress to cardiovascular disease pathogenesis.
- To assess the clinical utility of antioxidant therapy in cardiovascular disease.
Main Methods:
- Systematic review of human studies focusing on oxidative stress markers.
- Analysis of clinical trials investigating antioxidant therapy benefits in cardiovascular disease.
Main Results:
- Strong evidence supports oxidative stress involvement in atherosclerosis, endothelial dysfunction, platelet aggregation, and heart failure.
- Clinical benefits of antioxidant therapy in cardiovascular disease prevention are not established.
Conclusions:
- Oxidative stress is a key factor in cardiovascular disease development.
- Antioxidant therapy is not currently recommended for primary or secondary prevention of cardiovascular disease based on available evidence.
Objective:
To assess the evidence supporting the role of oxidative stress in the pathogenesis of atherosclerosis, endothelial dysfunction, platelet aggregation and heart failure, and to evaluate the status of antioxidant therapy in the clinical management of cardiovascular disease.
Data Sources:
No attempt was made to provide insight into mechanisms of oxidative stress and the response to antioxidant intervention. Human studies were scrutinized for evidence that oxidative stress was present and whether antioxidant therapy provides clinical benefit.
Conclusions:
There is ample evidence that oxidative stress is involved in the pathogenesis of atherosclerosis, endothelial dysfunction, platelet aggregation and heart failure. However, the extrapolation of this evidence to the use of antioxidant therapy in primary or secondary prevention of cardiovascular disease cannot be justified at this time.